HOOKIPA Pharma Inc.
HOOK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 118.3% | 41.3% | -22.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 93.7% | 82.4% | 74.7% | 74.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -93% | -384.2% | -423.9% | -380.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -99% | -405.3% | -455.6% | -410.2% |
| EPS Diluted | -3.47 | -8.63 | -9.91 | -23.04 |
| % Growth | 59.8% | 12.9% | 57% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |